ReviewFrontiers in oncology2024

Analysis on the pathogenesis and treatment progress of NRG1 fusion-positive non-small cell lung cancer.

Hongyan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.